WO2001047587A1 - Slide valve for syringes, and plunger for slide valve-equipped syringes - Google Patents

Slide valve for syringes, and plunger for slide valve-equipped syringes Download PDF

Info

Publication number
WO2001047587A1
WO2001047587A1 PCT/JP2000/009291 JP0009291W WO0147587A1 WO 2001047587 A1 WO2001047587 A1 WO 2001047587A1 JP 0009291 W JP0009291 W JP 0009291W WO 0147587 A1 WO0147587 A1 WO 0147587A1
Authority
WO
WIPO (PCT)
Prior art keywords
syringe
sliding valve
valve
plunger
slide valve
Prior art date
Application number
PCT/JP2000/009291
Other languages
French (fr)
Japanese (ja)
Inventor
Tetsuro Higashikawa
Original Assignee
Medical Information Services, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Information Services, Inc. filed Critical Medical Information Services, Inc.
Publication of WO2001047587A1 publication Critical patent/WO2001047587A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513Piston constructions to improve sealing or sliding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M2005/1787Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
    • A61M5/286Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
    • A61M2005/287Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst by displacing occluding plugs

Definitions

  • the present invention relates to a slide valve for a syringe, particularly a slide valve most suitable for a syringe-type kit preparation, and a plunger for a syringe with a slide valve having such a slide valve at the tip.
  • Injectables need to be slowly introduced into the body in order to work safely and effectively, and therefore the sliding valve needs to move smoothly.
  • the present invention provides a sliding valve for a syringe that slides extremely smoothly, and a plunger for a syringe with a sliding valve that has a sliding valve that slides extremely smoothly, which solves the above-mentioned problems of the prior art. That is the subject.
  • the slide valve for a syringe is a substantially cylindrical slide valve for a syringe, wherein the annular lip contacts an inner wall of the syringe cylinder and divides a space before and after the slide valve into a watertight manner. , And so that the substantially cylindrical axis of the slide valve is in contact with the inner wall of the syringe barrel and coincides with the axis of the syringe barrel.
  • the annular lip or holding part at the top of the sliding valve traveling direction at the time of injection is provided at a distance from the end (leading end) of the substantially cylindrical sliding valve. This is a slide valve for injectors.
  • annular lip or holding portion is provided at the end of a conventional sliding valve for a syringe, for example, a cylindrical sliding valve as shown in FIGS. 6 (a) and 6 (b). Eliminates the difficulty of sliding with a certain syringe slide valve.
  • the annular lip or the holding part at the rearmost part in the traveling direction of the slide valve is also provided at a distance from the rear end of the substantially cylindrical slide valve. Is desirable.
  • the effect of the present invention is maximized if the slide valve is a syringe for a kit preparation having a plurality of slide valves in one injection cylinder. Be demonstrated.
  • the sliding valve for a syringe of the present invention is made of rubber in which a lubricating component is chemically bonded or plastic in which a lubricating component is chemically bonded, it is currently used as a lubricant.
  • silicone oil which is partly questioned for its safety. This effect is remarkable in the case of a kit product for a syringe having a long contact time between the chemical solution and the sliding valve portion.
  • the plunger for a syringe with a sliding valve is a plunger for a syringe with a sliding valve having a substantially cylindrical sliding valve portion at the tip of the plunger portion, as described in claim 4, wherein An annular lip that contacts and divides the space before and after the sliding valve portion in a watertight manner; And a ring-shaped lip or holding part at the head of the sliding valve in the direction of movement of the sliding valve during injection, of the holding part which is in contact with the inner wall of the syringe barrel and regulates the substantially cylindrical axis of the sliding valve part so as to coincide with the axis of the syringe barrel.
  • a cylindrical hollow coaxial with the substantially cylindrical sliding valve is provided inside the sliding valve.
  • a cylindrical tip is inserted into the plunger portion having a size smaller than the cylindrical hollow portion so as to leave an axial gap and / or a circumferential gap in the cylindrical hollow portion.
  • the sliding valve portion is held by the plunger portion by the cylindrical tip portion, and the cylindrical valve inside the sliding valve portion is positioned from the position of the leading annular lip or the holding portion in the traveling direction of the sliding valve portion.
  • the slidability can be further improved as compared with a case where only the structure of the sliding valve is improved.
  • the effect is maximized with a plunger with a sliding valve for a syringe-type kit formulation having a plurality of sliding valves inside.
  • the sliding valve portion is made of a rubber to which a lubricating component is chemically bonded or a plunger for a syringe with a sliding valve made of a plastic to which a lubricating component is chemically bonded,
  • the excellent slidability can be improved, and a safe syringe can be obtained without using a silicone oil which is partially questioned for safety. This effect is remarkable in a kit formulation for a syringe in which the contact time between the drug solution and the sliding valve portion is long.
  • the annular lip is provided so as to protrude in the circumferential direction of a substantially cylindrical slide valve for a syringe, is in contact with the inner wall of the syringe barrel, and has the slide valve (“slide valve” and “slide valve”).
  • the space before and after the “sliding valve” in conjunction with the “valve drive section” is divided into watertight (including airtight).
  • the annular lip is in contact with the inner wall of the syringe barrel, and the space before and after the sliding valve. Any shape can be used as long as it is divided into watertight.
  • the annular lip also functions as a holding portion that contacts the inner wall of the syringe barrel and regulates the substantially cylindrical axis of the slide valve so as to match the axis of the syringe barrel.
  • the holding portion is an annular lip which is provided so as to protrude in a circumferential direction of a substantially cylindrical slide valve for a syringe, and is in contact with an inner wall of the syringe cylinder and has a substantially cylindrical shape. Is regulated so as to coincide with the axis of the syringe barrel.
  • the shape of the holding portion is not limited as long as the holding portion is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical shaft of the slide valve so as to match the shaft of the syringe tube.
  • it includes a holding portion that is partially cut, but has a shape similar to that of an annular lip.
  • the sliding valve must have at least one annular lip. Usually has two or more annular lips, or one annular lip and one or more retainers.
  • the leading annular lip or holding portion in the sliding valve traveling direction is provided at a distance from an end (leading end) of the substantially cylindrical sliding valve. It is necessary.
  • This distance is at least 0.5 mm, preferably at least 1 mm, and more preferably at least 1.5 mm.
  • the end of the substantially cylindrical slide valve refers to the circumference of the end face of the slide valve in the traveling direction. Small end portions may be provided on this end face due to structural necessity. In such a case, the end portion is ignored. In addition, in some cases, this end face is formed into a very loose conical shape. In such a case, the circumference of the conical bottom face is considered to be the end of a substantially cylindrical sliding valve, and a ring is provided at a distance from this circumference. A lip or holding part is provided.
  • the leading annular lip or holding portion in the sliding valve traveling direction is provided at a distance from the end (leading end) of the substantially cylindrical sliding valve.
  • annular lip or holding portion is provided at the end of a conventional sliding valve for a syringe, for example, a cylindrical sliding valve as shown in FIGS. 6 (a) and 6 (b). Eliminates the difficulty of sliding with a certain syringe slide valve.
  • the annular lip or the holding part at the rear end of the slide valve in the direction of travel of the slide valve at the time of injection is also closer to the rear end of the substantially cylindrical slide valve. It is desirable to be provided at a distance.
  • Examples of the rubber in the present invention include nitrile rubber, hydrogenated nitrile rubber, ethylene-propylene-gen rubber, ethylene-propylene rubber, and butyl rubber.
  • Examples of the plastic include polyester, polyamide, polypropylene, polyolefin, and polyurethane.
  • plasticizers that may adversely affect the living body.
  • a synthetic oil-based lubricant is desirable as the lubricating component.
  • Such materials include, for example, hydrocarbon-based materials, polyglycol-based materials, silicone-based materials, and fluorine-based materials. These lubricating components are derivatized and chemically bonded to the rubber or plastic. Since the amount of lubricating components chemically bonded greatly affects lubricity, it is necessary to determine the amount by various studies.
  • bonding As a method of chemical bonding, general methods such as ordinary amide bond and ester bond are used.
  • the bonding may be carried out in stages, but a method in which a group which reacts with the crosslinking agent of the rubber'plastic is introduced into the lubricating component in advance, and the method is carried out simultaneously with the crosslinking.
  • a poorly reactive lubricant such as a fluororesin (polytetrafluoroethylene or a copolymer of tetrafluoroethylene and another comonomer)
  • an electrophilic reagent may be used. (Hindered phenols and Grignard reagents) can be added together with these lubricants at the time of molding to form a chemical bond simultaneously with the crosslinking reaction.
  • the size of the lubricant is preferably 10 m or more and 5 Om or less in diameter.
  • the addition amount is preferably from 5 to 60 parts by weight, more preferably from 10 to 50 parts by weight, based on 100 parts by weight of the rubber component.
  • a fluororesin and a silicone-based lubricant are used as a lubricating component.
  • the sliding valve moves very smoothly and the movement starts smoothly, so that injection into a predetermined location such as intravenous injection becomes easy.
  • the injection volume may be adjusted according to the patient instead of injecting the whole injection solution in the cylinder. This has the effect of making it extremely easy to inject.
  • the fluororesin and the silicone-based lubricant which are lubricants, can be used alone as a lubricating component, but by using both at the same time, better lubricity can be obtained.
  • the electrophile is compatible with the base rubber or plastic component and does not cause any obstacles.
  • Such compounds include hindered phenols, for example, pentaerythritylate trakis [3- (3,5-t-butyl-4-hydroxyphenyl) propionate], 2,2-thiodiethylenebis [3- (3,5-di_t-butyl-1-hydroxyphenyl) propionate], 2,2-thiobis (4-methyl_6-t-butyl Thiophenol), N, N'-bis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionyl] hydrazine, and the like, and Grignard reagents include salts and iodine.
  • electrophilic reagents are used in an amount of 0.1 to 10 parts by weight, particularly 0.2 to 5 parts by weight, based on 100 parts by weight of the base rubber or plastic component. .
  • lubricants and lubricants are blended with an electrophile, a rubber or plastic component, and a bridging agent.
  • injection molding is performed in a mold at a temperature of 140 ° C to 200 ° C, and By performing the crosslinking treatment by applying a pressure of usually 2 OMPa or less as needed, a sliding valve for a syringe in which a lubricating component is chemically bonded can be obtained.
  • the crosslinking can be carried out by a method known as a method for crosslinking these base rubber components or plastic components.
  • modifiers antioxidants, crosslinking assistants, processing assistants, reinforcing agents, softeners, coloring agents, extenders, antioxidants, ultraviolet absorbers, etc.
  • additives for example, they need to have safety as raw materials for sliding valves for syringes.
  • the syringe sliding valve in which the lubricating component is integrated with the rubber component or the plastic component by chemical bonding has a sufficient lubricating property.
  • the lubricating components may be mixed into the drug due to elution or peeling-off.
  • the sliding valve itself since the sliding valve itself has lubricating properties, it is not necessary to use a silicone coating treatment or a combined use with a lubricating film or the like, or the amount of the combined use can be reduced, and safety is enhanced.
  • Such a slide valve is also suitable as a slide valve for an ordinary syringe, but is particularly suitable as a slide valve for a syringe of a kit preparation having a long contact period with a chemical solution.
  • a commonly used material that is, a polyolefin-based material such as glass, polypropylene or amorphous polyolefin is used. Compounds can be adopted.
  • those having a cyclic olefin copolymer as a unit satisfy safety, heat resistance, cold resistance, transparency, high precision, gas barrier properties, chemical resistance, and other properties required for syringes. It is desirable because it is easy.
  • annular slide valves for syringes, and have annular lips (b1, b2, or b3) that contact the inner wall of the syringe barrel and divide the space before and after the slide valve a in a watertight manner.
  • the holding part c 1 or c 2
  • the annular lip or the holding portion is a sliding valve for a syringe provided inside at a distance from an end of the substantially cylindrical sliding valve.
  • FIG. 1 (a) has two sine-shaped annular lips b1, and FIG. 1 (b) shows one wavy annular lip b2 and a ring-shaped annular lip b2. Indicates a sliding valve having one and two.
  • Fig. 1 (c) shows a sliding valve with a single annular lip b3 in the shape of a combination of two wave shapes (a sea-wall pattern), and Fig. 1 (d) shows a ring-shaped valve. A sliding valve with two annular lips b2 is shown.
  • the sliding valve shown in Fig. 1 (e) and Fig. 1 (f) is suitable as an intermediate sliding valve (middle stopper).
  • These sliding valves include a plurality of holding portions c 1 ( ⁇ -shaped) and c 2 (c) for making the axis of the substantially cylindrical sliding valve in contact with the inner wall of the injection cylinder always coincide with the axis of the injection cylinder. “W” shape) is formed.
  • the shape of the holding portion may be substantially the same as that of the annular lip, and may be partly discontinuous in a “C” shape.
  • the appearance is the same as that of the annular lip, Section, a tunnel section, and the like, and as a result, the space before and after the section may not be divided in a watertight manner.
  • these sections are also referred to as holding sections.
  • Such an intermediate slide valve has a large liquid contact area due to its shape, so when silicone coating is applied, there is a concern that the silicone compound elutes into the chemical liquid compared to a normal shape slide valve. There is.
  • the lubricating component is made of rubber chemically bonded or the lubricating component is made of plastic chemically bonded, the silicone coating is unnecessary or the amount used can be reduced.
  • FIG. 2 an example in which the present invention is applied to a sliding valve for a syringe in the present invention will be described with reference to FIG. 2.
  • An annular lip that divides the space in a watertight manner a holding part (six in this example) that is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical shaft of the slide valve so that it matches the axis of the syringe cylinder.
  • a holding part (six in this example) that is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical shaft of the slide valve so that it matches the axis of the syringe cylinder.
  • Is the front surface of the sliding valve body An intermediate sliding valve main body A 1 having a bypass hole 3 penetrating from the rear surface to a rear surface thereof; and a bypass mosquito L 3 inner wall formed around a side surface near one bottom side of a columnar body longer than the bypass hole 3.
  • a sealing valve 10 is formed to contact the airtight and water-tightly divides the space before and after it, and has a groove-shaped liquid passage 11 reaching the bottom of the other side from the portion in contact with the sealing valve on the side surface, and slides into the bypass hole 3. It consists of a slide valve A2 that is movably housed, and the direction of travel of the slide valve at the time of injection. The first annular lip or holding part is located at a distance from the end of the substantially cylindrical slide valve.
  • the intermediate slide valve A for a syringe-type kit preparation having a substantially cylindrical shape is shown.
  • a holding portion 2 is provided at a distance from an end face 4 which is an end of the substantially cylindrical sliding valve.
  • an annular lip 1 is provided at a distance 8 from the end face 5 which is the end of the substantially cylindrical slide valve.
  • FIGS. 2 (a) and 2 (b) are views of FIG. 2 (g) obliquely from the right.
  • FIGS. 2 (a) and 2 (b) show the state of the intermediate sliding valve body A1 alone
  • FIGS. FIG. 3 is a view showing a state of the slide valve A2 alone.
  • FIGS. 2 (e) and 2 (f) show a state in which the slide valve A2 is slidably housed in the bypass hole 3 of the intermediate slide valve body A1 (state before use). At this time, the sealing valve 10 of the slide valve A2 is in contact with the inner wall of the bypass hole 3, and the bypass hole 3 is sealed. It is in a state of being left.
  • the intermediate sliding valve advances leftward by the injection operation, and the left side surface 12 of the slide valve A2 comes into contact with the bottom surface of the syringe barrel (not shown) on the injection needle side.
  • A2 slides leftward relative to the intermediate sliding valve main body A1, and the seal formed by the sealing valve 10 and the bypass hole 3 is released, and the intermediate sliding valve A
  • the chemical solution (not shown) on the left side can move to the right side (injection needle side) of the slide valve A2 through the space between the groove-shaped liquid passage 11 of the slide valve A2 and the inner wall of the bypass hole 3.
  • FIG. 3 (a) Reference numeral 21 indicates a glass syringe (normal).
  • a lidocaine hydrochloride (infiltration anesthetic) liquid is filled as a first agent 25 in a watertight space formed by the injection cylinder 21 and the intermediate sliding valve A of this kit preparation.
  • the injection cylinder 21, the intermediate slide valve A, and the plunger slide valve 22 (the plunger slide valve 22 is also a substantially cylindrical slide valve according to the present invention, and is in contact with the inner wall of the syringe cylinder.
  • the leading annular lip in the direction of travel of the sliding valve during injection is provided at a distance from the end of the substantially cylindrical sliding valve.
  • the injection needle connection part 21 a of the injection cylinder 21 is sealed by a cap 24 made of resin or rubber.
  • the cap 24 Prior to use of such a kit preparation, the cap 24 is removed as shown in FIG. 3 (b), and the injection needle 27 is attached to the injection needle connection portion 21a of the injection cylinder 21. At this time, by operating the plunger operation part 22 a with the injection needle side facing up, even if there is air that has entered the part of the first agent 25 when the needle is attached, it can be completely removed. Can be. If it is necessary to reduce the injection amount of the first agent 25, the plunger operation section 22a is operated at this stage to reduce the injection amount.
  • the injection needle 27 is pierced into the required injection site, and then the plunger operation part 22a is moved to the tip end of the syringe cylinder to inject the first agent 25.
  • the second agent 26 behind the intermediate slide valve A reaches the needle 27 through the formed bypass fluid passage, and is injected.
  • the injection is completed as shown in Fig. 3 (d).
  • the injection operation may be ended with the second agent 26 remaining in the syringe 1.
  • the kit preparation according to the present invention has the intermediate sliding valve A inside the injection cylinder 21, and the mechanism of the intermediate sliding valve A prevents the injection solutions 25 and 26 from mixing.
  • the injection can be performed surely sequentially, since the intermediate sliding valve A and the plunger sliding valve 22 are related to the present invention, the injection can be performed with an extremely smooth operation feeling in these operations.
  • a slide valve having the shape shown in Fig. 4 (a) (the center is a cross-sectional view, the left side is a left side view, and the right side is a right side view) is a substantially cylindrical syringe plunger slide valve (prior art) according to the prior art.
  • Comparison Example 1) 30 which is compatible with a 5 ml syringe.
  • annular lips 31 to 33 that contact the inner wall of the injection cylinder of the sliding valve and divide the space before and after the sliding valve in a watertight manner, among the annular lips 3 1 to 33 in the leading direction of the sliding valve during injection, 1 is provided at the end 34 of the substantially cylindrical sliding valve, and the rearmost annular lip 33 is provided at the rear end 37 of the substantially cylindrical sliding valve.
  • Reference numeral 35 denotes a convex portion for securing a passage for the chemical solution immediately before the end of the injection
  • reference numeral 36 denotes a plunger (not shown). It is a convex portion for preventing it from coming off.
  • the slide valve having the shape shown in FIG. 4 (b) (the center is a sectional view, the left side is a left side view, and the right side is a right side view) is a substantially cylindrical slide valve for a syringe according to the present invention (implementation).
  • 1 is a plunger sliding valve for a syringe provided at a distance (1.6 mm) from the end 44 of the substantially cylindrical sliding valve, and the rear annular lip 43 is also substantially cylindrical. It is provided at a distance (1.6 mm) from the rear end 47 of the slide valve.
  • the slide valve 40 has the same shape and size as the syringe slide valve 30 except for the positions of the annular lips 41 and 43.
  • FIG. 5 shows a plunger 50 (Example 2) for a syringe with a sliding valve according to the present invention 50 having a substantially cylindrical sliding valve portion 50a at the tip of the plunger portion 50b (Example 2).
  • the annular lips 5 1 to 5 3 that contact the inner wall and divide the space before and after the sliding valve portion in a water-tight manner, among the annular lips 5 1 to 5 3, the leading annular lip in the sliding valve traveling direction at the time of injection 5 1
  • the sliding valve portion 50a is provided at a distance from the end of the portion 50a, and a cylindrical hollow portion 58 coaxial with the substantially cylindrical sliding valve portion is provided inside the sliding valve portion 50a.
  • Cylindrical tip The sliding valve portion 50a is held by the plunger portion 50b by the cylindrical distal end portion 50b1 and the sliding valve portion 50a is inserted. From the position of the annular lip 51 at the leading end in the traveling direction, the bottom of the cylindrical hollow portion 58 inside the sliding valve portion 50a is located at the distal end side of the sliding valve portion 50a. 1 mm) is a plunger for a syringe with a sliding valve.
  • the structure and dimensions of the sliding valve portion 50a of the plunger 50 for a syringe with a sliding valve are the same as those of the sliding valve 40 except for the structure of the cylindrical hollow portion therein.
  • silicone oil is applied so that they have the same thickness. Apply it and set it in a glass syringe. At that time, without a syringe needle and without filling with a drug solution, the head speed was 10 mmZ for 6 seconds (injection volume: 1.1 m I 6 (Speed equivalent to seconds) Adjusted using an autograph manufactured by Shimadzu Corporation.
  • the evaluation was performed by averaging the operating force of a total of 5 points at the start (start of measurement), immediately before the end of measurement, and at points (3 points) where the distance was divided into five equal parts.
  • butyl rubber Natural Rubber, butyl 268
  • filler Natural Rubber, butyl 268
  • zinc oxide zinc oxide
  • zeo colloid
  • 2-mercaptobenzothiazole M; large
  • Uchi-Shinko Chemical zinc dibutyldithiocarbamate
  • BZ Ouchi-Shinko Chemical
  • TT tetramethylthiuram disulfide
  • polytetrafluoroethylene powder as a lubricant PTFE powder, particle diameter of 20 m or more and 30 m or less
  • silicone-based grease as a lubricant Table 1 composition unvulcanized rubber composition obtained by mixing so that the weight ratio shown in 1 in the mold 1 6 0 ° C '1 5 minutes, at 1 3 0 kg pressure of Z cm 2 It was heated to form a sliding valve.
  • Table 1 shows the results obtained when the force of the sliding valve of Comparative Example 1 was set to 100 for the force required for the operation at this time.
  • Table 1 shows that the force required for operating the sliding valve according to the present invention is clearly smaller than that of the sliding valve according to the prior art.
  • a drug solution injection test was performed. This is a monitor test using a glass syringe with 10 physicians as monitors.
  • the test was performed using saline as the injection solution and attaching a 25 G (gauge) needle assuming intravenous injection. Evaluate the feel of the plunger at the start of pushing (initial slidability) and the ease (interruptability) when interrupting at the total injection volume of 13 (10 levels), with 10 being the best and 1 being the best. The result was averaged, and the result was rounded off. Table 2 shows the results. At this time, the details of the samples were not explained for each monitor, and they were performed in any order. Table 2 shows the results 2]
  • Table 2 shows that the operability of the sliding valves according to the present invention in Examples 1 to 4 was remarkably good.
  • a 25 G needle was attached assuming intravenous injection, and a test was performed by 10 physicians in the same manner as described above. The presence or absence of “squeaky feeling” was also evaluated, and the number of people concerned about the squeaky feeling was examined.
  • Table 3 shows the results. (Table 3)
  • Table 3 shows that the sliding valves according to the present invention are significantly better in Examples 1 to 4 in the experiment in which the kit preparation was taken into consideration. In addition, it can be seen that the sliding valves of Examples 1 to 4 have almost completely eliminated the squeakiness caused by the sliding valve of Comparative Example 1.
  • the sliding valve for a syringe according to the present invention is an excellent sliding valve for a syringe that can be extremely smoothly slid due to its unique configuration and that can be injected into a stable place with little failure during injection.
  • 1 (a) to 1 (f) are diagrams showing examples of the shape of the sliding valve of the present invention.
  • FIG. 2 is a view showing an intermediate sliding valve A for a syringe-type kit preparation.
  • (a), (b) is a diagram showing an intermediate sliding valve body A1.
  • (c), (d) is a view showing a slide valve A2.
  • (e), (f) is a diagram showing an intermediate sliding valve A for a syringe-type kit formulation by combining the intermediate sliding valve body A1 and the slide valve A2.
  • FIG. 3 (a) to (d) are diagrams showing an operation method of an example of a kit preparation using an in-line sequential injection syringe having an intermediate slide valve A for a syringe-type kit preparation.
  • (a) is a diagram showing a sliding valve according to the prior art.
  • (b) is a view showing a sliding valve according to the present invention.
  • (c) is an overall sectional view.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A substantially columnar slide valve for syringes, wherein one of the two parts, an annular lip contacting the inner wall surface of an injection barrel to water-tightly divide spaces before and after the slide valve and a holder contacting the inner wall surface of the injection barrel to control the substantially columnar stem of the slide valve so that the stem coincides with the axis of the injection barrel, the annular lip or holder at the head in the direction of travel of the slide valve during injection is installed at some distance away from the end of the substantially columnar slide valve, the slide valve enabling smooth injecting operation .

Description

明細書  Specification
注射器用摺動弁、 及び、 摺動弁付き注射器用プランジャ Sliding valve for syringe and plunger for syringe with sliding valve
[技術分野] [Technical field]
本発明は注射器用摺動弁、 特に注射器型キット製剤に最適な摺動弁及びそのよ うな摺動弁を先端に有する摺動弁付き注射器用プランジャに関する。  The present invention relates to a slide valve for a syringe, particularly a slide valve most suitable for a syringe-type kit preparation, and a plunger for a syringe with a slide valve having such a slide valve at the tip.
[背景技術]  [Background technology]
注射剤は安全上及び有効に働くためには緩徐に体内へ導入される必要があリ、 そのために摺動弁の動きはなめらかである必要がある。  Injectables need to be slowly introduced into the body in order to work safely and effectively, and therefore the sliding valve needs to move smoothly.
しかし、 複数の薬剤を混合することなく順次注射することができる直列順次分 注型注射器の場合、 プランジャによって直接駆動される通常の摺動弁以外に、 注 射筒内部にあって前後の空間を水密に分割する中間摺動弁が 1個以上用いられる ために、 通常の注射器よリ注射動作の操作感が重くなるのは避けられない。  However, in the case of a serial sequential dispensing syringe that can sequentially inject a plurality of drugs without mixing, in addition to the usual sliding valve directly driven by the plunger, the front and rear spaces inside the injection cylinder Since one or more intermediate sliding valves that divide water-tightly are used, it is inevitable that the operational feeling of the re-injection operation becomes heavier than a normal syringe.
また、 ヒアルロン酸ナトリウム溶液等の高粘度溶液を注射する場合は通常の、 プランジャによって直接駆動される通常の摺動弁のみを有する注射器であっても 操作感が重〈なる。  In addition, when a high viscosity solution such as a sodium hyaluronate solution is injected, even a normal syringe having only a normal sliding valve directly driven by a plunger has a great operational feeling.
このような操作感が重いと、 緩徐に体内へ注射できなくなり、 また、 注射中に 必要箇所 (静脈、 関節腔など) から針先がそれて失敗することがあり、 さらに、 患者に激痛を与えたりするなど予想外の問題となることがある。  If such a feeling of operation is heavy, injection into the body can not be carried out slowly, and the needle tip may deviate from necessary points (veins, joint cavities, etc.) during injection, and may cause severe pain to the patient. May cause unexpected problems.
本発明は、 上記従来技術の問題点を解決する、 極めて滑らかに摺動する注射器 用摺動弁、 及び、 極めて滑らかに摺動する摺動弁を有する摺動弁付き注射器用プ ランジャを提供することをその課題とする。  The present invention provides a sliding valve for a syringe that slides extremely smoothly, and a plunger for a syringe with a sliding valve that has a sliding valve that slides extremely smoothly, which solves the above-mentioned problems of the prior art. That is the subject.
[発明の開示]  [Disclosure of the Invention]
本発明の注射器用摺動弁は請求項 1に記載の通り、 略円柱形の注射器用摺動弁 であって、 注射筒内壁に接し該摺動弁の前後の空間を水密に分割する環状リップ 、 及び、 注射筒内壁に接し該摺動弁の略円柱形の軸を注射筒の軸に合致するよう 規制する保持部のうち、 注射時の摺動弁進行方向先頭の環状りップまたは保持部 が、 略円柱形の摺動弁の端部 (先頭側端部) より距離をおいて設けられている注 射器用摺動弁である。 As set forth in claim 1, the slide valve for a syringe according to the present invention is a substantially cylindrical slide valve for a syringe, wherein the annular lip contacts an inner wall of the syringe cylinder and divides a space before and after the slide valve into a watertight manner. , And so that the substantially cylindrical axis of the slide valve is in contact with the inner wall of the syringe barrel and coincides with the axis of the syringe barrel. Of the holding parts that are regulated, the annular lip or holding part at the top of the sliding valve traveling direction at the time of injection is provided at a distance from the end (leading end) of the substantially cylindrical sliding valve. This is a slide valve for injectors.
このような構成により、 従来の注射器用摺動弁、 例えば、 第 6図 (a ) および 第 6図 (b ) に示したような円筒形の摺動弁の端部に環状リップあるいは保持部 がある注射器用摺動弁での摺動しにくさが解消する。  With this configuration, an annular lip or holding portion is provided at the end of a conventional sliding valve for a syringe, for example, a cylindrical sliding valve as shown in FIGS. 6 (a) and 6 (b). Eliminates the difficulty of sliding with a certain syringe slide valve.
これは従来の注射器用摺動弁では、 注射時の操作の過程で力が加わったときに 生じる変形によって環状リップが注射筒内壁に向かって強く押しつけられて摺動 性が著しく損なわれていたのが、 本発明の上記特有の構成により、 摺動性が損な われることなく注射できる。  This is because in a conventional sliding valve for a syringe, the annular lip was strongly pressed against the inner wall of the syringe cylinder due to the deformation generated when a force was applied during the operation of injection, and the slidability was significantly impaired. However, the above-described specific configuration of the present invention allows injection without impairing the slidability.
なお、 注射器の操作者が吸引操作を行うことがあるため、 摺動弁進行方向最後 部の環状リップまたは保持部も、 略円柱形の摺動弁の後方側端部より距離をおい て設けられていることが望ましい。  In addition, since the syringe operator may perform the suction operation, the annular lip or the holding part at the rearmost part in the traveling direction of the slide valve is also provided at a distance from the rear end of the substantially cylindrical slide valve. Is desirable.
本発明の注射器用摺動弁において、 請求項 2に記載のように、 1つの注射筒内 に複数の摺動弁を有するキット製剤用注射器摺動弁であると、 本発明の効果が最 大限発揮される。  In the slide valve for a syringe according to the present invention, as described in claim 2, the effect of the present invention is maximized if the slide valve is a syringe for a kit preparation having a plurality of slide valves in one injection cylinder. Be demonstrated.
さらに、 請求項 3に記載のように、 本発明の注射器用摺動弁が潤滑成分が化学 結合されたゴム、 または、 潤滑成分が化学結合されだプラスチックからなると、 潤滑材として現状用いられているものの、 その安全性において一部疑問視されて いるシリコーンオイルを用いることなく、 潤滑成分の脱離のない極めて安全な注 射を行うことが可能となる。 なお、 この効果は、 薬液と摺動弁部との接触時間が 長い注射器用キッ卜製剤において顕著である。  Further, as described in claim 3, when the sliding valve for a syringe of the present invention is made of rubber in which a lubricating component is chemically bonded or plastic in which a lubricating component is chemically bonded, it is currently used as a lubricant. However, it is possible to perform extremely safe injection without desorption of lubricating components without using silicone oil, which is partly questioned for its safety. This effect is remarkable in the case of a kit product for a syringe having a long contact time between the chemical solution and the sliding valve portion.
本発明の摺動弁付き注射器用プランジャは、 請求項 4に記載の通り、 略円柱形 の摺動弁部をプランジャ部の先端に有する摺動弁付き注射器用プランジャであつ て、 注射筒内壁に接し該摺動弁部の前後の空間を水密に分割する環状リップ、 及 び、 注射筒内壁に接し該摺動弁部の略円柱形の軸を注射筒の軸に合致するよう規 制する保持部のうち、 注射時の摺動弁進行方向先頭の環状リップまたは保持部が 略円柱形の摺動弁部の端部 (先端側端部) より距離をおいて設けられており、 摺 動弁部の内部に略円柱状の摺動弁部と同軸な円柱状の中空部が設けられ、 この円 柱状の中空部に軸方向の間隙及び 又は円周方向の間隙を残すように該円柱状の 中空部より小さい大きさとしたプランジャ部の円柱状の先端部が挿入されて該円 柱状の先端部により該摺動弁部がプランジャ部に保持され、 かつ、 摺動弁部の進 行方向先頭の環状りップまたは保持部の位置より摺動弁部内部の円柱状の中空部 の先端側底部の位置が、 摺動弁部進行方向先端側に位置する摺動弁付き注射器用 プランジャである。 The plunger for a syringe with a sliding valve according to the present invention is a plunger for a syringe with a sliding valve having a substantially cylindrical sliding valve portion at the tip of the plunger portion, as described in claim 4, wherein An annular lip that contacts and divides the space before and after the sliding valve portion in a watertight manner; And a ring-shaped lip or holding part at the head of the sliding valve in the direction of movement of the sliding valve during injection, of the holding part which is in contact with the inner wall of the syringe barrel and regulates the substantially cylindrical axis of the sliding valve part so as to coincide with the axis of the syringe barrel. Is provided at a distance from the end (front end) of the substantially cylindrical sliding valve, and a cylindrical hollow coaxial with the substantially cylindrical sliding valve is provided inside the sliding valve. A cylindrical tip is inserted into the plunger portion having a size smaller than the cylindrical hollow portion so as to leave an axial gap and / or a circumferential gap in the cylindrical hollow portion. The sliding valve portion is held by the plunger portion by the cylindrical tip portion, and the cylindrical valve inside the sliding valve portion is positioned from the position of the leading annular lip or the holding portion in the traveling direction of the sliding valve portion. The plunge for a syringe with a sliding valve, where the bottom of the hollow part at the tip side is located on the tip side in the sliding valve part traveling direction. It is.
このような構成によリ、 摺動弁の構造のみを改良した場合よリもさらに摺動性 が良好なものとすることができ、 特に、 請求項 5に記載のように、 1つの注射筒 内に複数の摺動弁を有する注射器型キッ卜製剤用摺動弁付きプランジャでその効 果を最大限発揮する。  According to such a configuration, the slidability can be further improved as compared with a case where only the structure of the sliding valve is improved. The effect is maximized with a plunger with a sliding valve for a syringe-type kit formulation having a plurality of sliding valves inside.
さらに、 請求項 6に記載のように上記摺動弁部が潤滑成分が化学結合されたゴ ム、 または、 潤滑成分が化学結合されたプラスチックからなる摺動弁付き注射器 用プランジャとすることにより、 その優れた摺動性を向上させることができ、 一 部で安全性が疑問視されているシリコーンオイルの併用を行わずに安全な注射器 を得ることができる。 この効果は、 薬液と摺動弁部との接触時間が長い注射器用 キッ卜製剤において顕著である。  Further, as described in claim 6, the sliding valve portion is made of a rubber to which a lubricating component is chemically bonded or a plunger for a syringe with a sliding valve made of a plastic to which a lubricating component is chemically bonded, The excellent slidability can be improved, and a safe syringe can be obtained without using a silicone oil which is partially questioned for safety. This effect is remarkable in a kit formulation for a syringe in which the contact time between the drug solution and the sliding valve portion is long.
本発明において、 環状リップとは略円筒形の注射器用摺動弁の円周方向に突出 して設けられたもので、 注射筒内壁に接し、 その摺動弁 (「摺動弁」 と 「摺動弁部 」 と併せて 「摺動弁」 とも云う) の前後の空間を水密 (気密も含む) に分割する ものである。  In the present invention, the annular lip is provided so as to protrude in the circumferential direction of a substantially cylindrical slide valve for a syringe, is in contact with the inner wall of the syringe barrel, and has the slide valve (“slide valve” and “slide valve”). The space before and after the “sliding valve” in conjunction with the “valve drive section” is divided into watertight (including airtight).
本発明において、 環状リップは、 注射筒内壁に接し、 その摺動弁の前後の空間 を水密に分割するかぎり、 その形状を問わない。 In the present invention, the annular lip is in contact with the inner wall of the syringe barrel, and the space before and after the sliding valve. Any shape can be used as long as it is divided into watertight.
なお、 この環状リップはさらに、 注射筒内壁に接し該摺動弁の略円柱形の軸を 注射筒の軸に合致するよう規制する保持部としての働きも同時に有する。  The annular lip also functions as a holding portion that contacts the inner wall of the syringe barrel and regulates the substantially cylindrical axis of the slide valve so as to match the axis of the syringe barrel.
また、 本発明において、 保持部とは、 環状リップとは略円筒形の注射器用摺動 弁の円周方向に突出して設けられたもので、 注射筒内壁に接し該摺動弁の略円柱 形の軸を注射筒の軸に合致するよう規制するものである。  Further, in the present invention, the holding portion is an annular lip which is provided so as to protrude in a circumferential direction of a substantially cylindrical slide valve for a syringe, and is in contact with an inner wall of the syringe cylinder and has a substantially cylindrical shape. Is regulated so as to coincide with the axis of the syringe barrel.
本発明において、 保持部は注射筒内壁に接し該摺動弁の略円柱形の軸を注射筒 の軸に合致するよう規制するかぎりにおいてその形状を問わない。 例えば、 一部 が切断されているものの、 環状リップに形状的に似た形状である保持部も含む。 本発明において、 摺動弁は少なくとも 1つの環状リップを有する必要がある。 通常、 環状リップ 2つか、 あるいは 1つの環状リップと 1つ以上の保持部を有す る。  In the present invention, the shape of the holding portion is not limited as long as the holding portion is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical shaft of the slide valve so as to match the shaft of the syringe tube. For example, it includes a holding portion that is partially cut, but has a shape similar to that of an annular lip. In the present invention, the sliding valve must have at least one annular lip. Usually has two or more annular lips, or one annular lip and one or more retainers.
本発明の注射器用摺動弁において、 摺動弁進行方向先頭の環状リップまたは保 持部が、 略円柱形の摺動弁の端部 (先頭側端部) より距離をおいて設けられてい ることが必要である。  In the sliding valve for a syringe according to the present invention, the leading annular lip or holding portion in the sliding valve traveling direction is provided at a distance from an end (leading end) of the substantially cylindrical sliding valve. It is necessary.
この距離としては 0 . 5 mm以上、 望ましくは 1 mm以上、 さらに望ましくは 1 . 5 mm以上である。 なお、 略円柱形の摺動弁の端部とは摺動弁進行方向端面 の周を云う。 この端面に構造上の必要から小さい凸部が設けられている場合があ るがその場合にはその凸部を無視する。 また、 この端面が極めて緩い円錐状にな つている場合があるが、 その場合には、 該円錐底面の周をもって略円柱形の摺動 弁の端部と考え、 この周から距離をおいて環状リップまたは保持部を設ける。 本発明の摺動弁では、 このように摺動弁進行方向先頭の環状リップまたは保持 部が、 略円柱形の摺動弁の端部 (先頭側端部) より距離をおいて設けられている ことにより、 プランジャ操作時に生じる圧力による摺動弁の変形による摺動弁の 環状りップ及び保持部が注射筒内壁に押しつけられる力が極端に大きくなること を防ぐことができるので、 スムーズな注射動作が可能となる。 This distance is at least 0.5 mm, preferably at least 1 mm, and more preferably at least 1.5 mm. Note that the end of the substantially cylindrical slide valve refers to the circumference of the end face of the slide valve in the traveling direction. Small end portions may be provided on this end face due to structural necessity. In such a case, the end portion is ignored. In addition, in some cases, this end face is formed into a very loose conical shape. In such a case, the circumference of the conical bottom face is considered to be the end of a substantially cylindrical sliding valve, and a ring is provided at a distance from this circumference. A lip or holding part is provided. In the sliding valve of the present invention, the leading annular lip or holding portion in the sliding valve traveling direction is provided at a distance from the end (leading end) of the substantially cylindrical sliding valve. As a result, the force that presses the annular lip and the holding portion of the sliding valve against the inner wall of the injection cylinder due to the deformation of the sliding valve due to the pressure generated when the plunger is operated becomes extremely large Can be prevented, so that a smooth injection operation can be performed.
このような構成により、 従来の注射器用摺動弁、 例えば、 第 6図 (a ) および 第 6図 (b ) に示したような円筒形の摺動弁の端部に環状リップあるいは保持部 がある注射器用摺動弁での摺動しにくさが解消する。  With this configuration, an annular lip or holding portion is provided at the end of a conventional sliding valve for a syringe, for example, a cylindrical sliding valve as shown in FIGS. 6 (a) and 6 (b). Eliminates the difficulty of sliding with a certain syringe slide valve.
これは従来の注射器用摺動弁では、 注射時の操作の過程で力が加わったときに 生じる変形によって環状リップが注射筒内壁に向かって強く押しつけられて摺動 性が著しく損なわれていたのが、 本発明の上記特有の構成により、 摺動性が損な われることなく注射できる。  This is because in a conventional sliding valve for a syringe, the annular lip was strongly pressed against the inner wall of the syringe cylinder due to the deformation generated when a force was applied during the operation of injection, and the slidability was significantly impaired. However, the above-described specific configuration of the present invention allows injection without impairing the slidability.
なお、 注射器の操作者が薬液等の吸引操作を行うことがあるため、 注射時の摺 動弁進行方向最後部の環状リップまたは保持部も、 略円柱形の摺動弁の後方側端 部より距離をおいて設けられていることが望ましい。  In addition, since the syringe operator may perform the suction operation of the drug solution, etc., the annular lip or the holding part at the rear end of the slide valve in the direction of travel of the slide valve at the time of injection is also closer to the rear end of the substantially cylindrical slide valve. It is desirable to be provided at a distance.
本発明におけるゴムとしては、 二トリルゴム、 水素添加二卜リルゴム、 ェチレ ンープロピレン一ジェンゴム、 エチレン一プロピレンゴム、 ブチルゴムなどが挙 げられる。 また、 プラスチックとしてはポリエステル系、 ポリアミ ド系、 ポリプ ロピレン系、 ポリオレフイン系、 ポリウレタン系などが挙げられる。  Examples of the rubber in the present invention include nitrile rubber, hydrogenated nitrile rubber, ethylene-propylene-gen rubber, ethylene-propylene rubber, and butyl rubber. Examples of the plastic include polyester, polyamide, polypropylene, polyolefin, and polyurethane.
なお、 これらは生体に悪影響を及ぼすおそれのある可塑剤等の有機物や無機物 These are organic or inorganic substances such as plasticizers that may adversely affect the living body.
、 有害金属等を溶出させるおそれのない、 あるいはそれらを含まない医薬用途に 適したものである必要がある。 さらに、 このものは、 少なくとも、 目的の薬剤に 対して耐薬性があるものでなければならない。 It must be suitable for pharmaceutical use without the risk of eluting harmful metals, etc. or containing them. In addition, it must be at least resistant to the drug of interest.
本発明において、 潤滑成分としては、 合成油系の潤滑材が望ましい。 このよう なものとしては、 例えば炭化水素系ゃポリグリコール系、 シリコーン系、 或いは フッ素系のものが挙げられる。 これら潤滑成分を誘導化し上記ゴムまたはプラス チックに化学結合させる。 化学結合される潤滑成分量は潤滑性に大きな影響を及 ぼすため、 種々検討して決定する必要がある。  In the present invention, as the lubricating component, a synthetic oil-based lubricant is desirable. Such materials include, for example, hydrocarbon-based materials, polyglycol-based materials, silicone-based materials, and fluorine-based materials. These lubricating components are derivatized and chemically bonded to the rubber or plastic. Since the amount of lubricating components chemically bonded greatly affects lubricity, it is necessary to determine the amount by various studies.
化学結合の方法としては、 通常のアミ ド結合、 エステル結合などの一般的な手 段で結合させても良いが、 予めゴム'プラスチックの架橋剤と反応する基を潤滑 成分に導入しておいて架橋時と同時に行う方法も採用できる。 As a method of chemical bonding, general methods such as ordinary amide bond and ester bond are used. The bonding may be carried out in stages, but a method in which a group which reacts with the crosslinking agent of the rubber'plastic is introduced into the lubricating component in advance, and the method is carried out simultaneously with the crosslinking.
また、 フッ素樹脂 (ポリ亍トラフルォロエチレンや、 テトラフルォロエチレン と他のコモノマーとの共重合体等) などの反応性に乏しい潤滑材を潤滑成分とし て用いる場合には、 求電子試薬 (ヒンダードフ Iノール類やグリニャール試薬な ど) をこれら潤滑材と共に成形時に添加して、 架橋反応と同時に化学結合させる ことができる。  In addition, when a poorly reactive lubricant such as a fluororesin (polytetrafluoroethylene or a copolymer of tetrafluoroethylene and another comonomer) is used as a lubricating component, an electrophilic reagent may be used. (Hindered phenols and Grignard reagents) can be added together with these lubricants at the time of molding to form a chemical bond simultaneously with the crosslinking reaction.
潤滑材の大きさとしては直径 1 0 m以上 5 O m以下であることが好ましい 。 添加量はゴム成分 1 0 0重量部に対し 5重量部以上 6 0重量部以下、 特に 1 0 重量部以上 5 0重量部であることが好ましい。  The size of the lubricant is preferably 10 m or more and 5 Om or less in diameter. The addition amount is preferably from 5 to 60 parts by weight, more preferably from 10 to 50 parts by weight, based on 100 parts by weight of the rubber component.
以下、 フッ素樹脂及びシリコーン系潤滑剤を潤滑成分として用いる例について 詳細に説明する。 すなわち、 フッ素樹脂あるいはシリコーン系潤滑剤を潤滑成分 とした場合、 摺動弁の動きが非常になめらかで、 その動き始めがスムーズである ので、 静脈注射などの所定箇所への注射が容易になるのは勿論であるが、 その他 例えば、 キッ卜製剤などの場合シリンダー内にある注射液全部を注射するのでは なく、 患者に合わせて注入量を調整することがあるが、 このような場合も所定量 の注射が極めて容易になるなどの効果がある。 なお、 潤滑材であるフッ素樹脂及 びシリコーン系潤滑剤は、 単独で潤滑成分として用い得るが、 両者を同時に使用 することにより、 さらに良好な潤滑性を得ることができる。  Hereinafter, an example in which a fluororesin and a silicone-based lubricant are used as a lubricating component will be described in detail. In other words, when a fluororesin or silicone-based lubricant is used as the lubricating component, the sliding valve moves very smoothly and the movement starts smoothly, so that injection into a predetermined location such as intravenous injection becomes easy. Needless to say, in addition, for example, in the case of kit preparations, the injection volume may be adjusted according to the patient instead of injecting the whole injection solution in the cylinder. This has the effect of making it extremely easy to inject. Note that the fluororesin and the silicone-based lubricant, which are lubricants, can be used alone as a lubricating component, but by using both at the same time, better lubricity can be obtained.
上記において、 求電子試薬はベースのゴム成分またはプラスチック成分に対し て相溶性があり、 かつ、 障害を引き起こさないのであることが必要である。 この ようなものとしてはヒンダードフエノール類、 例えば、 ペンタエリスリチルーテ トラキス [ 3— ( 3, 5— t—プチルー 4—ヒドロキシフエニル) プロピオネー ト]、 2, 2—チォ一ジエチレンビス [ 3— (3, 5—ジ _ t —ブチル一4ーヒド ロキシフエニル) プロピオネート]、 2, 2—チォビス (4—メチル _ 6— t—ブ チルフエノール)、 N , N ' 一ビス [ 3— ( 3, 5—ジー tーブチルー 4—ヒ ドロ キシフエニル) プロピオニル] ヒドラジン等、 及びグリニャール試薬として、 塩 含ヨウ素のものが挙げられる。 In the above, it is necessary that the electrophile is compatible with the base rubber or plastic component and does not cause any obstacles. Such compounds include hindered phenols, for example, pentaerythritylate trakis [3- (3,5-t-butyl-4-hydroxyphenyl) propionate], 2,2-thiodiethylenebis [3- (3,5-di_t-butyl-1-hydroxyphenyl) propionate], 2,2-thiobis (4-methyl_6-t-butyl Thiophenol), N, N'-bis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionyl] hydrazine, and the like, and Grignard reagents include salts and iodine.
これら求電子試薬は通常ベースとなるゴム成分またはプラスチック成分 1 0 0 重量部に対し、 0 . 1重量部以上 1 0重量部以下、 特に 0 . 2重量部以上 5重量 部以下配合することが望ましい。  It is desirable that these electrophilic reagents are used in an amount of 0.1 to 10 parts by weight, particularly 0.2 to 5 parts by weight, based on 100 parts by weight of the base rubber or plastic component. .
これら潤滑剤■潤滑材を求電子試薬、 ゴム成分またはプラスチック成分及び架 橋剤と配合し、 例えば射出成形して金型内で 1 4 0 °C以上 2 0 0 °C以下の温度で 3 0分以下、 必要に応じて通常 2 O M P a以下の圧力を加えて架橋処理を行うこ とにより潤滑成分が化学結合された注射器用摺動弁を得ることができる。 なお、 架橋はこれらベースとなるゴム成分またはプラスチック成分の架橋方法として知 られる方法で行うことができる。  These lubricants and lubricants are blended with an electrophile, a rubber or plastic component, and a bridging agent. For example, injection molding is performed in a mold at a temperature of 140 ° C to 200 ° C, and By performing the crosslinking treatment by applying a pressure of usually 2 OMPa or less as needed, a sliding valve for a syringe in which a lubricating component is chemically bonded can be obtained. The crosslinking can be carried out by a method known as a method for crosslinking these base rubber components or plastic components.
なお、 上記以外に、 必要に応じ各種改質剤 (老化防止剤、 架橋助剤、 加工助剤 、 補強剤、 軟化剤、 着色剤、 増量剤、 酸化防止剤あるいは紫外線吸収剤等) を添 加することができるが、 当然それらは注射器用摺動弁原料としての安全性を有す るものである必要がある。  In addition to the above, various modifiers (antioxidants, crosslinking assistants, processing assistants, reinforcing agents, softeners, coloring agents, extenders, antioxidants, ultraviolet absorbers, etc.) are added as necessary. Of course, they need to have safety as raw materials for sliding valves for syringes.
本発明の注射器用摺動弁 (摺動弁付き注射器用プランジャ) において、 化学結 合により潤滑成分をゴム成分またはプラスチック成分と一体とした注射器摺動弁 は、 充分な潤滑性を有しながらも、 潤滑成分が溶出あるいは剥離■脱離等によつ て薬剤への混入するおそれが全くなくなる。 また、 摺動弁自体が潤滑性を有する ようになるため、 シリコーンコ一ティング処理や潤滑膜等との併用が不要となり 、 あるいは、 併用量を少なくすることができ、 安全性が高まる。 このような摺動 弁は、 通常の注射器の摺動弁としても適しているが、 特に薬液と接触期間が長い キッ卜製剤の注射器用摺動弁として適している。 なお、 本発明の摺動弁 (摺動弁付き注射器用プランジャ) と組み合わせてシリ ンジを形成するシリンダー部の材質としては、 通常用いられるもの、 すなわち、 ガラス、 ポリプロピレンやアモルファスポリオレフイン等のポリオレフイン系重 合物などが採用できる。 特に環状ォレフィンコポリマーをュニットとして有する ものが、 安全性、 耐熱■耐寒性、 透明性、 高精度、 ガスバリア性、 耐薬性、 その 他の注射器に求められる諸性能を満足し、 使用後焼却処分が容易であるため望ま しい。 In the sliding valve for a syringe of the present invention (the plunger for a syringe with a sliding valve), the syringe sliding valve in which the lubricating component is integrated with the rubber component or the plastic component by chemical bonding has a sufficient lubricating property. However, there is no risk that the lubricating components may be mixed into the drug due to elution or peeling-off. Further, since the sliding valve itself has lubricating properties, it is not necessary to use a silicone coating treatment or a combined use with a lubricating film or the like, or the amount of the combined use can be reduced, and safety is enhanced. Such a slide valve is also suitable as a slide valve for an ordinary syringe, but is particularly suitable as a slide valve for a syringe of a kit preparation having a long contact period with a chemical solution. As the material of the cylinder part which forms the syringe in combination with the sliding valve of the present invention (the plunger for a syringe with a sliding valve), a commonly used material, that is, a polyolefin-based material such as glass, polypropylene or amorphous polyolefin is used. Compounds can be adopted. In particular, those having a cyclic olefin copolymer as a unit satisfy safety, heat resistance, cold resistance, transparency, high precision, gas barrier properties, chemical resistance, and other properties required for syringes. It is desirable because it is easy.
[発明を実施するための最良の形態]  [Best Mode for Carrying Out the Invention]
以下、 本発明の摺動弁の形状について、 図を用いて具体的に説明する。  Hereinafter, the shape of the sliding valve of the present invention will be specifically described with reference to the drawings.
第 1図 (a ) 〜 (f ) に、 本発明の摺動弁の形状例を示す。  1 (a) to (f) show examples of the shape of the sliding valve of the present invention.
これらはいずれも、 略円柱形の注射器用摺動弁であって、 注射筒内壁に接し摺 動弁 aの前後の空間を水密に分割する環状リップ (b 1、 b 2、 または b 3 )、 及 び、 注射筒内壁に接し該摺動弁の略円柱形の軸を注射筒の軸に合致するよう規制 する保持部 (c 1または c 2 ) のうち、 注射時の摺動弁進行方向先頭の環状リッ プまたは保持部が、 略円柱形の摺動弁の端部より距離をおいて内側に設けられて いる注射器用摺動弁である。  These are generally cylindrical slide valves for syringes, and have annular lips (b1, b2, or b3) that contact the inner wall of the syringe barrel and divide the space before and after the slide valve a in a watertight manner. And of the holding part (c 1 or c 2), which is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical axis of the slide valve so as to match the axis of the syringe cylinder, in the leading direction of the slide valve at the time of injection. The annular lip or the holding portion is a sliding valve for a syringe provided inside at a distance from an end of the substantially cylindrical sliding valve.
第 1図 (a ) は略サイン波形の環状りップ b 1を 2条有するものであり、 第 1 図 (b ) は波線形の環状リップ b 2が 1条とリング形状の環状リップ b 2が 1条 とを有する摺動弁を示す。  FIG. 1 (a) has two sine-shaped annular lips b1, and FIG. 1 (b) shows one wavy annular lip b2 and a ring-shaped annular lip b2. Indicates a sliding valve having one and two.
第 1図 (c ) は 2つの波線形を組み合わせた形状 (なまこ壁模様状) の環状リ ップ b 3を 1条有する摺動弁が、 また、 第 1図 (d ) にはリング形状の環状リツ プ b 2を 2条有する摺動弁が示してある。  Fig. 1 (c) shows a sliding valve with a single annular lip b3 in the shape of a combination of two wave shapes (a sea-wall pattern), and Fig. 1 (d) shows a ring-shaped valve. A sliding valve with two annular lips b2 is shown.
第 1図 ( e ) 及び第 1図 ( f ) に示した摺動弁は、 中間摺動弁 (ミ ドルストッ パー) として適したものである。  The sliding valve shown in Fig. 1 (e) and Fig. 1 (f) is suitable as an intermediate sliding valve (middle stopper).
注射器型キッ卜製剤で行われる真空充填■真空打栓法によってキット製剤を作 成した場合、 すなわち、 第 1図 (a ) や第 1図 (b ) に示した摺動弁ではそれぞ れ符号 、 'で示した空間、 すなわち、 2つの環状リップと注射筒内壁とで形成 される空間が減圧状態となり、 環状リップと注射筒との間を通って薬液が入り込 み、 操作者にキット製剤に対する不信を抱かせる場合がある。 しかし、 第 1図 ( e ) 及び第 1図 (f ) に示した摺動弁には、 注射筒内壁に接し該摺動弁の前後の 空間を水密に分割する環状リップが 1つしかないため、 減圧された閉じた空間が ないのでこのような問題が生じない。 これら摺動弁には、 注射筒内壁に接して略 円筒形の摺動弁の軸を注射筒の軸に常に一致させるための複数の保持部 c 1 ( Γハ 」 字型) 及び c 2 (「W」 字型) が形成されている。 Vacuum filling performed with a syringe-type kit product ■ In the sliding valve shown in FIG. 1 (a) and FIG. 1 (b), the space indicated by the symbol, ′, ie, the space formed by the two annular lips and the inner wall of the injection cylinder, respectively, The space created is decompressed, and drug solution may enter between the annular lip and the syringe, causing the operator to distrust the kit. However, the sliding valve shown in FIGS. 1 (e) and 1 (f) has only one annular lip which contacts the inner wall of the syringe barrel and divides the space before and after the sliding valve in a watertight manner. However, since there is no decompressed closed space, such a problem does not occur. These sliding valves include a plurality of holding portions c 1 (Γ-shaped) and c 2 (c) for making the axis of the substantially cylindrical sliding valve in contact with the inner wall of the injection cylinder always coincide with the axis of the injection cylinder. “W” shape) is formed.
なお、 保持部の形状としては環状リップとほぼ同様の形状でその一部が不連続 の 「C」 字状のものであっても、 また、 見かけは環状リップと同じであるが、 ノく ィパス部、 トンネル部などを有し、 その結果、 その前後の空間を水密に分割する ことのないものであっても良く、 本発明ではこれらも保持部と云う。  The shape of the holding portion may be substantially the same as that of the annular lip, and may be partly discontinuous in a “C” shape. In addition, although the appearance is the same as that of the annular lip, Section, a tunnel section, and the like, and as a result, the space before and after the section may not be divided in a watertight manner. In the present invention, these sections are also referred to as holding sections.
このような中間摺動弁はその形状から接液面積が大きく、 そのためシリコーン コーティングを行った場合には、 通常の形状の摺動弁に比べ、 薬液へのシリコー ン化合物の溶出の不安を与える場合がある。 しかし、 潤滑成分が化学結合された ゴムまたは潤滑成分が化学結合されたプラスチックから構成することによりため 、 シリコーンコーティングが不要乃至使用量を減らすことができるため、 このよ うなシリコーン化合物による不安をなくす、 或いは、 最少に抑えることができる さらに、 本発明に注射器用摺動弁を中問摺動弁に応用した例について説明する 第 2図には、 注射筒内壁に接し中間摺動弁本体部の前後の空間を水密に分割す る環状リップ 1、 注射筒内壁に接し該摺動弁の略円柱形の軸を注射筒の軸に合致 するよう規制する保持部 (この例では 6個) 2と中間摺動弁本体部の前方の面か ら後方の面へ貫通するバイパス孔 3とを有する中間摺動弁本体部 A 1と、 該バイ パス孔 3よりも長い柱状体であって一方の底部側付近側面周囲に該バイパス孑 L 3 内壁に接しその前後の空間を水密に分割する密閉弁 1 0が形成され、 側面の密閉 弁に接した箇所から他方の底部に達する溝状の液通路 1 1を有し、 バイパス孔 3 内に摺動可能に収納されるスライド弁 A 2とからなり、 注射時の摺動弁進行方向 先頭の環状リップまたは保持部が、 略円柱形の摺動弁の端部より距離をおいて設 けられている略円柱形の注射器型キット製剤用中間摺動弁 Aを示す。 Such an intermediate slide valve has a large liquid contact area due to its shape, so when silicone coating is applied, there is a concern that the silicone compound elutes into the chemical liquid compared to a normal shape slide valve. There is. However, since the lubricating component is made of rubber chemically bonded or the lubricating component is made of plastic chemically bonded, the silicone coating is unnecessary or the amount used can be reduced. In addition, an example in which the present invention is applied to a sliding valve for a syringe in the present invention will be described with reference to FIG. 2. FIG. An annular lip that divides the space in a watertight manner, a holding part (six in this example) that is in contact with the inner wall of the syringe cylinder and regulates the substantially cylindrical shaft of the slide valve so that it matches the axis of the syringe cylinder. Is the front surface of the sliding valve body An intermediate sliding valve main body A 1 having a bypass hole 3 penetrating from the rear surface to a rear surface thereof; and a bypass mosquito L 3 inner wall formed around a side surface near one bottom side of a columnar body longer than the bypass hole 3. A sealing valve 10 is formed to contact the airtight and water-tightly divides the space before and after it, and has a groove-shaped liquid passage 11 reaching the bottom of the other side from the portion in contact with the sealing valve on the side surface, and slides into the bypass hole 3. It consists of a slide valve A2 that is movably housed, and the direction of travel of the slide valve at the time of injection. The first annular lip or holding part is located at a distance from the end of the substantially cylindrical slide valve. The intermediate slide valve A for a syringe-type kit preparation having a substantially cylindrical shape is shown.
この摺動弁が図中左側に進行した場合、 その略円柱形の摺動弁の端部である端 面 4から距離 をおいて保持部 2が設けられている。 また図中右側に進行した場 合、 その略円柱形の摺動弁の端部である端面 5から距離; 8をおいて環状リップ 1 が設けられている。  When the sliding valve advances to the left in the figure, a holding portion 2 is provided at a distance from an end face 4 which is an end of the substantially cylindrical sliding valve. When traveling to the right in the figure, an annular lip 1 is provided at a distance 8 from the end face 5 which is the end of the substantially cylindrical slide valve.
なお、 この中間摺動弁 Aは注射時に図方向右に進行した場合には環状リップ 1 が進行方向先頭の環状リップとなり、 図方向左に進行した場合には保持部 2が進 行方向先頭の保持部となる (これらの場合ではバイパス孔 3にスライド弁 A 2を セットする方向が互いに逆になる。)。  When the intermediate sliding valve A advances to the right in the drawing direction at the time of injection, the annular lip 1 becomes the leading annular lip in the traveling direction, and when the intermediate sliding valve A proceeds to the left in the drawing direction, the holding unit 2 moves to the leading end in the traveling direction. (In these cases, the directions in which the slide valve A2 is set in the bypass hole 3 are opposite to each other.)
以下にはこの中間摺動弁 Aが注射時に図中左方向に進行する場合について説明 する。  The case where the intermediate sliding valve A advances to the left in the figure at the time of injection will be described below.
第 2図 (b )、 第 2図 (d )、 第 2図 ( f ) 及び第 2図 (h ) はそれぞれ第 2図 ( a )、 第 2図 (c:)、 第 2図 (e ) 及び第 2図 (g ) を右斜めから見た図である 第 2図 (a ) 及び (b ) は中間摺動弁本体部 A 1単独の状態を、 第 2図 (c ) 及び (d ) はスライド弁 A 2単独の状態を示した図である。  Fig. 2 (b), Fig. 2 (d), Fig. 2 (f) and Fig. 2 (h) are Fig. 2 (a), Fig. 2 (c :), Fig. 2 (e), respectively. FIGS. 2 (a) and 2 (b) are views of FIG. 2 (g) obliquely from the right. FIGS. 2 (a) and 2 (b) show the state of the intermediate sliding valve body A1 alone, and FIGS. FIG. 3 is a view showing a state of the slide valve A2 alone.
さらに第 2図 (e ) 及び ( f ) はスライド弁 A 2を中間摺動弁本体部 A 1のバ ィパス孔 3内に摺動可能に収納した状態 (使用前の状態) を示す。 このときスラ ィド弁 A 2の密閉弁 1 0はバイパス孔 3の内壁に接し、 バイパス孔 3は密閉され た状態となっている。 2 (e) and 2 (f) show a state in which the slide valve A2 is slidably housed in the bypass hole 3 of the intermediate slide valve body A1 (state before use). At this time, the sealing valve 10 of the slide valve A2 is in contact with the inner wall of the bypass hole 3, and the bypass hole 3 is sealed. It is in a state of being left.
この中間摺動弁が注射操作により左方向に進行し、 スライド弁 A 2の左側の面 1 2が注射筒 (図示しない) の注射針側底部面に当接し、 さらにプランジャ操作 を行うとスライド弁 A 2が中間摺動弁本体部 A 1に対して相対的に左方向にスラ ィドして、 密閉弁 1 0とバイパス孔 3とによって形成された密閉が解除されて中 間摺動弁 A左側にある薬液 (図示しない) がスライド弁 A 2の溝状の液通路 1 1 とバイパス孔 3の内壁との間の空間を通ってこの摺動弁右側 (注射針側) に移動 できる。  The intermediate sliding valve advances leftward by the injection operation, and the left side surface 12 of the slide valve A2 comes into contact with the bottom surface of the syringe barrel (not shown) on the injection needle side. A2 slides leftward relative to the intermediate sliding valve main body A1, and the seal formed by the sealing valve 10 and the bypass hole 3 is released, and the intermediate sliding valve A The chemical solution (not shown) on the left side can move to the right side (injection needle side) of the slide valve A2 through the space between the groove-shaped liquid passage 11 of the slide valve A2 and the inner wall of the bypass hole 3.
次にこの中間摺動弁 Aを有する直列順次分注型注射器を用いるキッ卜製剤の例 の操作方法について第 3図 (a ) 〜 (d ) を用いて具体的に説明する。  Next, the operation method of an example of a kit preparation using a serial sequential dispensing syringe having the intermediate sliding valve A will be specifically described with reference to FIGS. 3 (a) to 3 (d).
第 3図 (a ) 中符号 2 1はガラス製注射筒 (通常のもの) を示す。  Fig. 3 (a) Reference numeral 21 indicates a glass syringe (normal).
このキッ卜製剤の注射筒 2 1、 中間摺動弁 Aにより構成される水密の空間に第 1剤 2 5として例えば塩酸リドカイン (浸潤麻酔剤) 液が充填されている。  For example, a lidocaine hydrochloride (infiltration anesthetic) liquid is filled as a first agent 25 in a watertight space formed by the injection cylinder 21 and the intermediate sliding valve A of this kit preparation.
また注射筒 2 1、 中間摺動弁 A及びプランジャ摺動弁 2 2 (このプランジャ摺 動弁 2 2も本発明に係る略円柱形の注射器用摺動弁であって、 注射筒内壁に接し 該摺動弁の前後の空間を水密に分割する環状リップのうち、 注射時の摺動弁進行 方向先頭の環状リップが、 略円柱形の摺動弁の端部より距離をおいて設けられて いる) からなる水密の空間に第 2剤 2 6として例えばヒアルロン酸ナトリウムが 充填されている。  In addition, the injection cylinder 21, the intermediate slide valve A, and the plunger slide valve 22 (the plunger slide valve 22 is also a substantially cylindrical slide valve according to the present invention, and is in contact with the inner wall of the syringe cylinder. Of the annular lips that divide the space before and after the sliding valve in a watertight manner, the leading annular lip in the direction of travel of the sliding valve during injection is provided at a distance from the end of the substantially cylindrical sliding valve. ) Is filled with, for example, sodium hyaluronate as the second agent 26.
注射筒 2 1の注射針接続部 2 1 aには樹脂またはゴムからなるキャップ 2 4に よって密閉されている。  The injection needle connection part 21 a of the injection cylinder 21 is sealed by a cap 24 made of resin or rubber.
このようなキット製剤は使用に先立ち、 第 3図 (b ) に示すようにキャップ 2 4が除去され、 注射筒 2 1の注射針接続部 2 1 aに注射針 2 7が装着される。 このとき、 注射針側を上にしてプランジャ操作部 2 2 aを操作することによリ 針装着時に第 1剤 2 5の部分に侵入した空気があった場合でも完全に除去するこ とができる。 なお、 第 1剤 2 5の注射量を少なくする必要がある場合には、 この 段階でプランジャ操作部 2 2 aを操作してその量を減らす。 Prior to use of such a kit preparation, the cap 24 is removed as shown in FIG. 3 (b), and the injection needle 27 is attached to the injection needle connection portion 21a of the injection cylinder 21. At this time, by operating the plunger operation part 22 a with the injection needle side facing up, even if there is air that has entered the part of the first agent 25 when the needle is attached, it can be completely removed. Can be. If it is necessary to reduce the injection amount of the first agent 25, the plunger operation section 22a is operated at this stage to reduce the injection amount.
次いで注射針 2 7を要注射部位に刺し、 その後プランジャ操作部 2 2 aを注射 筒先端側に移動する操作を行って第 1剤 2 5を注射する。  Next, the injection needle 27 is pierced into the required injection site, and then the plunger operation part 22a is moved to the tip end of the syringe cylinder to inject the first agent 25.
中間摺動弁 Aが注射筒先端側終点に達して第 1剤 2 5の注射が完了し、 第 2剤 2 6の注射開始直前の状態を第 3図 (c ) に示す。  The state immediately before the injection of the first agent 25 is completed when the intermediate slide valve A reaches the end point on the distal end side of the syringe cylinder and the injection of the second agent 26 is shown in FIG. 3 (c).
このとき、 中間摺動弁 Aのスライド弁 A 2が摺動して第 2図 (g ) および (h ) に示す状態となるため、 中間摺動弁 A後方の第 2剤 2 6がスライド弁 A 2の溝 状の液通路 1 1とバイパス孔 3の内壁との間の空間を通ってこの摺動弁 Aの右側 (注射針 2 7側) に移動可能となる。  At this time, since the slide valve A2 of the intermediate slide valve A slides to the state shown in FIGS. 2 (g) and 2 (h), the second agent 26 behind the intermediate slide valve A becomes the slide valve. Through the space between the groove-shaped liquid passage 11 of A 2 and the inner wall of the bypass hole 3, the slide valve A can move to the right side (the injection needle 27 side) of the sliding valve A.
上記に続けてプランジャ 2 2 aの操作が継続されると、 形成されたバイパス通 液路を通過して中間摺動弁 A後方の第 2剤 2 6が針 2 7に達して注射され、 最終 的に第 3図 (d ) に示すように注射が完了する。 なお、 第 2剤 2 6の注射量を少 なくする必要があるとき、 第 2剤 2 6が注射筒 1内に残った状態で注射操作を終 了しても良い。  When the operation of the plunger 22a is continued following the above, the second agent 26 behind the intermediate slide valve A reaches the needle 27 through the formed bypass fluid passage, and is injected. The injection is completed as shown in Fig. 3 (d). When it is necessary to reduce the injection amount of the second agent 26, the injection operation may be ended with the second agent 26 remaining in the syringe 1.
上記のように本発明に係るキッ卜製剤では、 注射筒 2 1内部に中間摺動弁 Aを 有し、 この中間摺動弁 Aの機構により注射液 2 5と 2 6とを混合することなく確 実に順次注射できるが、 中間摺動弁 A及びプランジャ摺動弁 2 2が本発明に係る ものであるため、 これら操作において、 極めて滑らかな操作感で注射を行うこと ができる。  As described above, the kit preparation according to the present invention has the intermediate sliding valve A inside the injection cylinder 21, and the mechanism of the intermediate sliding valve A prevents the injection solutions 25 and 26 from mixing. Although the injection can be performed surely sequentially, since the intermediate sliding valve A and the plunger sliding valve 22 are related to the present invention, the injection can be performed with an extremely smooth operation feeling in these operations.
[実施例]  [Example]
以下に本発明の実施例を示す。  Hereinafter, examples of the present invention will be described.
まず、 実験に用いた摺動弁の形状について説明する。  First, the shape of the sliding valve used in the experiment will be described.
第 4図 (a ) に示した形状の摺動弁 (中央が断面図、 その左側が左側面図、 右 側が右側面図) は、 従来技術に係る略円柱形の注射器用プランジャ摺動弁 (比較 例 1 ) 3 0であって、 5 m Iの注射器に適合するものである。 A slide valve having the shape shown in Fig. 4 (a) (the center is a cross-sectional view, the left side is a left side view, and the right side is a right side view) is a substantially cylindrical syringe plunger slide valve (prior art) according to the prior art. Comparison Example 1) 30 which is compatible with a 5 ml syringe.
この摺動弁の注射筒内壁に接し該摺動弁の前後の空間を水密に分割する環状リ ップ 3 1 〜 3 3のうち、 注射時の摺動弁進行方向先頭の環状りップ 3 1が略円柱 形の摺動弁の端部 3 4に、 さらに最後方の環状リップ 3 3も、 略円柱形の摺動弁 の後方側端部 3 7にそれぞれ設けられている。  Of the annular lips 31 to 33 that contact the inner wall of the injection cylinder of the sliding valve and divide the space before and after the sliding valve in a watertight manner, among the annular lips 3 1 to 33 in the leading direction of the sliding valve during injection, 1 is provided at the end 34 of the substantially cylindrical sliding valve, and the rearmost annular lip 33 is provided at the rear end 37 of the substantially cylindrical sliding valve.
なお、 符号 3 5は、 注射終了直前の薬液の通路を確保するための凸部を示し、 また、 符号 3 6はプランジャ (図示しない) 先端のねじ部をねじ込んだときにそ のねじ止めが容易に外れないようにするための外れ止め用の凸部である。  Reference numeral 35 denotes a convex portion for securing a passage for the chemical solution immediately before the end of the injection, and reference numeral 36 denotes a plunger (not shown). It is a convex portion for preventing it from coming off.
第 4図 (b ) に示した形状の摺動弁 (中央が断面図、 その左側が左側面図、 右 側が右側面図) は、 本発明に係る略円柱形の注射器用摺動弁 (実施例 1 ) 4 0で あって、 注射筒内壁に接し該摺動弁の前後の空間を水密に分割する環状リップ 4 1 〜4 3のうち、 注射時の摺動弁進行方向先頭の環状リップ 4 1が、 略円柱形の 摺動弁の端部 4 4から距離 (1 . 6 mm) をおいて設けられている注射器用ブラ ンジャ摺動弁であり、 後方の環状リップ 4 3も、 略円柱形の摺動弁の後方側端部 4 7から距離 (1 . 6 mm) をおいて設けられている。 なお、 この摺動弁 4 0は 環状リップ 4 1及び 4 3の位置以外は注射器用摺動弁 3 0と同一の形状■大きさ である。  The slide valve having the shape shown in FIG. 4 (b) (the center is a sectional view, the left side is a left side view, and the right side is a right side view) is a substantially cylindrical slide valve for a syringe according to the present invention (implementation). Example 1) 40, and among the annular lips 41 to 43 that contact the inner wall of the syringe barrel and divide the space before and after the sliding valve in a watertight manner, among the annular lips 4 1 to 43 in the leading direction of the sliding valve at the time of injection. 1 is a plunger sliding valve for a syringe provided at a distance (1.6 mm) from the end 44 of the substantially cylindrical sliding valve, and the rear annular lip 43 is also substantially cylindrical. It is provided at a distance (1.6 mm) from the rear end 47 of the slide valve. The slide valve 40 has the same shape and size as the syringe slide valve 30 except for the positions of the annular lips 41 and 43.
第 5図は略円柱形の摺動弁部 5 0 aをプランジャ部 5 0 bの先端に有する本発 明に係る摺動弁付き注射器用プランジャ 5 0 (実施例 2 ) であって、 注射筒内壁 に接し該摺動弁部の前後の空間を水密に分割する環状りップ 5 1 ~ 5 3のうち、 注射時の摺動弁進行方向先頭の環状リップ 5 1略円柱形の摺動弁部 5 0 aの端部 より距離をおいて設けられており、 摺動弁部 5 0 aの内部に略円柱状の摺動弁部 と同軸な円柱状の中空部 5 8が設けられ、 この円柱状の中空部に軸方向の間隙 ( 前後とも 0 . 5 mm) 及び円周方向 (全周にわたって 0 . 5 mm) の間隙を残す ように該円柱状の中空部より小さい大きさとしたプランジャ部の円柱状の先端部 5 0 b 1が挿入されて該円柱状の先端部 5 0 b 1によリ該摺動弁部 5 0 aがブラ ンジャ部 5 0 bに保持され、 かつ、 摺動弁部 5 0 aの進行方向先頭の環状リップ 5 1の位置よリ摺動弁部 5 0 a内部の円柱状の中空部 5 8の先端側底部 5 8匕の 位置が、 摺動弁部進行方向先端側 (0 . 1 mm) に位置する摺動弁付き注射器用 プランジャである。 FIG. 5 shows a plunger 50 (Example 2) for a syringe with a sliding valve according to the present invention 50 having a substantially cylindrical sliding valve portion 50a at the tip of the plunger portion 50b (Example 2). Of the annular lips 5 1 to 5 3 that contact the inner wall and divide the space before and after the sliding valve portion in a water-tight manner, among the annular lips 5 1 to 5 3, the leading annular lip in the sliding valve traveling direction at the time of injection 5 1 A substantially cylindrical sliding valve The sliding valve portion 50a is provided at a distance from the end of the portion 50a, and a cylindrical hollow portion 58 coaxial with the substantially cylindrical sliding valve portion is provided inside the sliding valve portion 50a. A plunger portion smaller than the cylindrical hollow portion so as to leave a gap in the axial direction (0.5 mm on both sides) and a circumferential direction (0.5 mm over the entire circumference) in the cylindrical hollow portion. Cylindrical tip The sliding valve portion 50a is held by the plunger portion 50b by the cylindrical distal end portion 50b1 and the sliding valve portion 50a is inserted. From the position of the annular lip 51 at the leading end in the traveling direction, the bottom of the cylindrical hollow portion 58 inside the sliding valve portion 50a is located at the distal end side of the sliding valve portion 50a. 1 mm) is a plunger for a syringe with a sliding valve.
なお、 この摺動弁付き注射器用プランジャ 5 0の摺動弁部 5 0 aの構造■寸法 はその内部の円柱状の中空部の構造以外は上記摺動弁 4 0と同一である。  The structure and dimensions of the sliding valve portion 50a of the plunger 50 for a syringe with a sliding valve are the same as those of the sliding valve 40 except for the structure of the cylindrical hollow portion therein.
[試験器による評価]  [Evaluation with tester]
このような 3種類の形状のブチルゴム製の摺動弁 (摺動弁 3 0及び摺動弁 4 0 にはそれぞれプランジャをねじ込んでセットした) を用い、 同一の厚さとなるよ うそれぞれシリコーンオイルを塗布し、 ガラス製注射器にセットし、 そのときの 摺動性を注射針は付けず、 薬液も充填せずに、 へッド速度 1 0 mmZ 6秒 (注射 量: 1, 1 m Iノ 6秒に相当する速度) で島津製作所製オートグラフを用いて調 ベニ。  Using these three types of butyl rubber slide valves (plungers are screwed into slide valve 30 and slide valve 40, respectively), silicone oil is applied so that they have the same thickness. Apply it and set it in a glass syringe. At that time, without a syringe needle and without filling with a drug solution, the head speed was 10 mmZ for 6 seconds (injection volume: 1.1 m I 6 (Speed equivalent to seconds) Adjusted using an autograph manufactured by Shimadzu Corporation.
測定開始と測定終了直前及びこれらの間を 5等分した箇所 (3点) の計 5点の 操作力を平均し、 評価を行った。  The evaluation was performed by averaging the operating force of a total of 5 points at the start (start of measurement), immediately before the end of measurement, and at points (3 points) where the distance was divided into five equal parts.
さらに、 それぞれ実施例 1、 実施例 2と同様の形状で、 かつ、 潤滑成分が化学 結合されたゴムからなる 2種の注射器用摺動弁 (実施例 3および 4 ) を作製し、 同様に評価を行った。  Further, two types of sliding valves for syringes (Examples 3 and 4) each having the same shape as those of Examples 1 and 2 and made of rubber to which a lubricating component is chemically bonded were prepared and evaluated in the same manner. Was done.
すなわち、 ブチルゴム (日本合成ゴム製、 ブチル 2 6 8 )、 フィラー (日本シリ 力製、 二ブシール V N 3 ) 酸化亜鉛、 ィォゥ (コロイドィォゥ)、 加硫促進剤とし て 2—メルカプトべンゾチアゾール (M;大内新興化学製)、 ジブチルジチォカル バミン酸亜鉛 (B Z :大内新興化学製)、 テトラメチルチウラムジスルフィ ド (T T :大内新興化学製)、 潤滑材であるポリ四ふつ化工チレン粉末 (P T F E粉末、 粒子径 2 0 m以上 3 0 m以下)、 及び潤滑剤であるシリコーン系グリ一スから 表 1の組成 1に示した重量比となるよう混合して得た未加硫ゴム組成物を金型内 で 1 6 0 °C ' 1 5分、 1 3 0 k g Z c m 2の加圧下で加熱して摺動弁として成形し た。 That is, butyl rubber (Nippon Synthetic Rubber, butyl 268), filler (Nippon Silicite, Nibusir VN 3 ), zinc oxide, zeo (colloid), 2-mercaptobenzothiazole (M; large) as a vulcanization accelerator Uchi-Shinko Chemical), zinc dibutyldithiocarbamate (BZ: Ouchi-Shinko Chemical), tetramethylthiuram disulfide (TT: Ouchi-Shinko Chemical), and polytetrafluoroethylene powder as a lubricant PTFE powder, particle diameter of 20 m or more and 30 m or less) and silicone-based grease as a lubricant Table 1 composition unvulcanized rubber composition obtained by mixing so that the weight ratio shown in 1 in the mold 1 6 0 ° C '1 5 minutes, at 1 3 0 kg pressure of Z cm 2 It was heated to form a sliding valve.
このときの操作に要した力について、 比較例 1の摺動弁での力を 1 0 0とした ときの結果を表 1に示す。  Table 1 shows the results obtained when the force of the sliding valve of Comparative Example 1 was set to 100 for the force required for the operation at this time.
〔表 1〕  〔table 1〕
Figure imgf000017_0001
表 1により、 本発明に係る摺動弁の操作に必要な力は従来技術に係る摺動弁に 比べ明らかに小さくなつていることが判る。
Figure imgf000017_0001
Table 1 shows that the force required for operating the sliding valve according to the present invention is clearly smaller than that of the sliding valve according to the prior art.
[薬液注射試験による評価]  [Evaluation by liquid injection test]
薬液注射試験を行った。 これは、 内科医 1 0人をモニターとし、 ガラスシリン ジを用いたモニタ一テストを行ったものである  A drug solution injection test was performed. This is a monitor test using a glass syringe with 10 physicians as monitors.
注射液として生理食塩水を用い、 静脈注射を想定して 2 5 G (ゲージ) の注射 針を付けてテストを行った。 プランジャーの押し始めの感触 (初期摺動性)、 総注 入量の 1 3で中断する場合の容易さ (取扱容易性) をそれぞれ 1 0段階評価し 、 1 0が最も良く、 1が最も悪いとし、 その結果を平均し、 小数点以下を四捨五 入した。 結果を表 2に示す。 なお、 この際、 各モニタ一にはサンプルの詳細につ いては説明せずに、 かつ、 順不同に行った。 結果を表 2に示す 2 ] The test was performed using saline as the injection solution and attaching a 25 G (gauge) needle assuming intravenous injection. Evaluate the feel of the plunger at the start of pushing (initial slidability) and the ease (interruptability) when interrupting at the total injection volume of 13 (10 levels), with 10 being the best and 1 being the best. The result was averaged, and the result was rounded off. Table 2 shows the results. At this time, the details of the samples were not explained for each monitor, and they were performed in any order. Table 2 shows the results 2]
Figure imgf000018_0001
Figure imgf000018_0001
表 2により、 本発明に係る摺動弁である実施例 1 〜 4を用いた場合の操作性は 著しく良好であることが判る。  Table 2 shows that the operability of the sliding valves according to the present invention in Examples 1 to 4 was remarkably good.
[キット製剤を想定した試験]  [Test assuming kit preparation]
さらに本発明に係る摺動弁をキット製剤に応用することを想定して実験を行つ た。 1 %プロボフォール溶液は乳化液であり、 注射筒に充填して長時間放置した 場合に、 プランジャ操作感が重くなる (「きしみ」 が生じる) 場合がある。 プラン ジャ操作感における 「きしみ感」 は、 静脈注射の場合、 確保した静脈から注射針 が外れる原因となる恐れがある。 この問題が本発明の摺動弁により解決できるか 検討を行った。  Further, experiments were conducted on the assumption that the slide valve according to the present invention is applied to a kit preparation. The 1% provophor solution is an emulsion, and when filled in a syringe and left for a long time, the plunger operation feeling may become heavy ("squeaking" may occur). The “squeaking feeling” in the plunger operation feeling may cause the needle to come off from the secured vein in the case of intravenous injection. We examined whether this problem could be solved by the sliding valve of the present invention.
上記、 比較例 1、 実施例 1 ~ 4の摺動弁付きプランジャをセットしたガラス製 注射筒に、 1 %のプロポフォール溶液 (5 m l ) を吸引し、 室温で 2 4時間放置 した。  A 1% propofol solution (5 ml) was sucked into a glass syringe in which the plungers with sliding valves of Comparative Example 1 and Examples 1 to 4 were set, and allowed to stand at room temperature for 24 hours.
その後、 静脈注射を想定して 2 5 Gの注射針を付けて内科医 1 0人によるテス トを上記同様に行った。 なお、 「きしみ感」 の有無についても評価を行い、 きしみ 感が気になった人の数を調べた。  Thereafter, a 25 G needle was attached assuming intravenous injection, and a test was performed by 10 physicians in the same manner as described above. The presence or absence of “squeaky feeling” was also evaluated, and the number of people concerned about the squeaky feeling was examined.
結果を表 3に示す。 〔表 3〕 Table 3 shows the results. (Table 3)
Figure imgf000019_0001
表 3により、 キット製剤を念頭においた実験においても本発明に係る摺動弁で ある実施例 1〜4での著しく良好であることが判る。 なお、 実施例 1〜4の摺動 弁では比較例 1の摺動弁で生じた 「きしみ」 惑が殆ど解消されていることが判る
Figure imgf000019_0001
Table 3 shows that the sliding valves according to the present invention are significantly better in Examples 1 to 4 in the experiment in which the kit preparation was taken into consideration. In addition, it can be seen that the sliding valves of Examples 1 to 4 have almost completely eliminated the squeakiness caused by the sliding valve of Comparative Example 1.
[発明の効果] [The invention's effect]
本発明の注射器用摺動弁はその特有の構成により、 極めて滑らかに摺動し、 注 射時の失敗がすくない、 安定した箇所に注射することができる優れた注射器用摺 動弁である。  The sliding valve for a syringe according to the present invention is an excellent sliding valve for a syringe that can be extremely smoothly slid due to its unique configuration and that can be injected into a stable place with little failure during injection.
[図面の簡単な説明]  [Brief description of drawings]
第 1図 (a) 〜 (f ) 本発明の摺動弁の形状例を示す図である。  1 (a) to 1 (f) are diagrams showing examples of the shape of the sliding valve of the present invention.
第 2図 注射器型キット製剤用中間摺動弁 Aを示す図である。  FIG. 2 is a view showing an intermediate sliding valve A for a syringe-type kit preparation.
(a)、 (b) 中間摺動弁本体部 A 1を示す図である。  (a), (b) is a diagram showing an intermediate sliding valve body A1.
(c)、 (d) スライド弁 A 2を示す図である。  (c), (d) is a view showing a slide valve A2.
(e)、 ( f ) 中間摺動弁本体部 A 1 とスライド弁 A 2とを組み合わせて注射 器型キット製剤用中間摺動弁 Aとした図である。  (e), (f) is a diagram showing an intermediate sliding valve A for a syringe-type kit formulation by combining the intermediate sliding valve body A1 and the slide valve A2.
(g)、 (h) 注射器型キット製剤用中間摺動弁 Aの使用した後の状態を示す 図である。 第 3図 (a) 〜 (d) 注射器型キット製剤用中間摺動弁 Aを有する直列順次分 注型注射器を用いるキット製剤の例の操作方法について示した図である。 (g), (h) shows the state after using the intermediate slide valve A for a syringe-type kit preparation. FIG. 3 (a) to (d) are diagrams showing an operation method of an example of a kit preparation using an in-line sequential injection syringe having an intermediate slide valve A for a syringe-type kit preparation.
第 4図  Fig. 4
(a) 従来技術に係る摺動弁を示す図である。  (a) is a diagram showing a sliding valve according to the prior art.
(b) 本発明に係る摺動弁を示す図である。  (b) is a view showing a sliding valve according to the present invention.
第 5図  Fig. 5
本発明に係る摺動弁付き注射器用プランジャを示す図である。  It is a figure showing the plunger for syringes with a slide valve concerning the present invention.
(a) 摺動弁部先端面を示す図である。  (a) It is a figure which shows the sliding valve part front end surface.
(b) 摺動弁部付近の断面図である。  (b) It is sectional drawing near a sliding valve part.
(c) 全体の断面図である。  (c) is an overall sectional view.
第 6図  Fig. 6
従来技術に係る摺動弁を示した図である。  It is a figure showing a sliding valve concerning a conventional technology.

Claims

請求の範囲 The scope of the claims
1 . 略円柱形の注射器用摺動弁であって、 注射筒内壁に接し該摺動弁の前後の空 間を水密に分割する環状リップ、 及び、 注射筒内壁に接し該摺動弁の略円柱形の 軸を注射筒の軸に合致するよう規制する保持部のうち、 注射時の摺動弁進行方向 先頭の環状リップまたは保持部が、 略円柱形の摺動弁の端部より距離をおいて設 けられていることを特徴とする注射器用摺動弁。  1. A substantially cylindrical slide valve for a syringe, which is in contact with the inner wall of the syringe cylinder and divides the space before and after the slide valve in a watertight manner, and an approximate lip of the slide valve which is in contact with the inner wall of the syringe cylinder. Of the holding part that regulates the cylindrical axis so that it matches the axis of the syringe barrel, the sliding valve travel direction at the time of injection The leading annular lip or holding part is located at a distance from the end of the substantially cylindrical sliding valve. A sliding valve for a syringe, characterized in that the sliding valve is provided.
2 . 上記注射器用摺動弁が、 1つの注射筒内に複数の摺動弁を有するキット製剤 用注射器摺動弁であることを特徴とする請求項 1に記載の注射器用摺動弁。  2. The slide valve for a syringe according to claim 1, wherein the slide valve for a syringe is a syringe slide valve for a kit preparation having a plurality of slide valves in one syringe.
3 . 上記注射器用摺動弁が潤滑成分が化学結合されたゴム、 または、 潤滑成分が 化学結合されたプラスチックからなることを特徴とする請求項 1または請求項 2 に記載の注射器用摺動弁。  3. The sliding valve for a syringe according to claim 1 or 2, wherein the sliding valve for a syringe is made of rubber having a lubricating component chemically bonded or plastic having a lubricating component chemically bonded. .
4. 略円柱形の摺動弁部をプランジャ部の先端に有する摺動弁付き注射器用ブラ ンジャであって、 注射筒内壁に接し該摺動弁部の前後の空間を水密に分割する環 状リップ、 及び、 注射筒内壁に接し該摺動弁部の略円柱形の軸を注射筒の軸に合 致するよう規制する保持部のうち、 注射時の摺動弁進行方向先頭の環状リップま たは保持部が略円柱形の摺動弁部の端部より距離をおいて設けられており、 摺動 弁部の内部に略円柱状の摺動弁部と同軸な円柱状の中空部が設けられ、 この円柱 状の中空部に軸方向の間隙及び/又は円周方向の間隙を残すように該円柱状の中 空部より小さい大きさとしたプランジャ部の円柱状の先端部が挿入されて該円柱 状の先端部によリ該摺動弁部がプランジャ部に保持され、 かつ、 摺動弁部の進行 方向先頭の環状リップまたは保持部の位置よリ摺動弁部内部の円柱状の中空部の 先端側底部の位置が、 摺動弁部進行方向先端側に位置することを特徴とする摺動 弁付き注射器用プランジャ  4. A syringe plunger with a sliding valve having a substantially cylindrical sliding valve at the tip of the plunger, wherein the ring is in contact with the inner wall of the syringe barrel and watertightly divides the space before and after the sliding valve. Of the lip and the holding portion which contacts the inner wall of the syringe barrel and regulates the substantially cylindrical shaft of the sliding valve portion so as to match the shaft of the syringe barrel, the leading annular lip in the sliding valve advancing direction at the time of injection. Alternatively, the holding portion is provided at a distance from the end of the substantially cylindrical sliding valve portion, and a cylindrical hollow portion coaxial with the substantially cylindrical sliding valve portion is provided inside the sliding valve portion. The cylindrical tip portion of the plunger portion having a size smaller than the cylindrical hollow portion is inserted so as to leave an axial gap and / or a circumferential gap in the cylindrical hollow portion. The sliding valve portion is held by the plunger portion by the cylindrical tip portion, and the leading end of the sliding valve portion in the traveling direction is moved forward. For a syringe with a sliding valve, characterized in that the position of the bottom of the cylindrical hollow portion inside the sliding valve portion is located on the tip side in the direction of travel of the sliding valve portion from the position of the lip or holding portion. Plunger
5 . 上記摺動弁付き注射器用プランジャが、 1つの注射筒内に複数の摺動弁を有 する注射器型キッ卜製剤用摺動弁付きプランジャであることを特徴とする請求項 4に記載の摺動弁付き注射器用プランジャ。 5. The plunger for a syringe with a slide valve is a plunger with a slide valve for a syringe-type kit preparation having a plurality of slide valves in one syringe. 4. The plunger for a syringe with a sliding valve according to 4.
6 . 上記摺動弁部が潤滑成分が化学結合されたゴム、 または、 潤滑成分が化学結 合されたプラスチックからなることを特徴とする請求項 4または請求項 5に記載 の摺動弁付き注射器用プランジャ。  6. The syringe with a sliding valve according to claim 4, wherein the sliding valve portion is made of rubber having a lubricating component chemically bonded or plastic having a lubricating component chemically bonded. Plunger.
PCT/JP2000/009291 1999-12-27 2000-12-27 Slide valve for syringes, and plunger for slide valve-equipped syringes WO2001047587A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP37034799 1999-12-27
JP11/370347 1999-12-27

Publications (1)

Publication Number Publication Date
WO2001047587A1 true WO2001047587A1 (en) 2001-07-05

Family

ID=18496680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/009291 WO2001047587A1 (en) 1999-12-27 2000-12-27 Slide valve for syringes, and plunger for slide valve-equipped syringes

Country Status (1)

Country Link
WO (1) WO2001047587A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376048A (en) * 2001-03-31 2002-12-04 David William Armfield An intermediate piston for dispensing sealant from a tube in sequence

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028201A1 (en) * 1995-03-13 1996-09-19 Taisho Pharmaceutical Co., Ltd. Prefilled syringe and method of sterilizing prefilled injection
JPH08266624A (en) * 1995-03-22 1996-10-15 Becton Dickinson & Co Stopper for injector
JPH11253557A (en) * 1998-03-10 1999-09-21 Tetsuo Tokawa Sliding valve for syringe, syringe and kit preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996028201A1 (en) * 1995-03-13 1996-09-19 Taisho Pharmaceutical Co., Ltd. Prefilled syringe and method of sterilizing prefilled injection
JPH08266624A (en) * 1995-03-22 1996-10-15 Becton Dickinson & Co Stopper for injector
JPH11253557A (en) * 1998-03-10 1999-09-21 Tetsuo Tokawa Sliding valve for syringe, syringe and kit preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376048A (en) * 2001-03-31 2002-12-04 David William Armfield An intermediate piston for dispensing sealant from a tube in sequence
GB2376048B (en) * 2001-03-31 2004-11-10 David William Armfield Pistons

Similar Documents

Publication Publication Date Title
CN204446979U (en) For setting up device and the armarium of aseptic connection
US10384008B2 (en) Syringe with needle, prefilled syringe, and medical liquid administration tool using the same
JP2021175510A (en) Drug delivery device and method
EP3756704B1 (en) Integrated sliding seal fluid pathway connection and drug containers for drug delivery pumps
JP3083134B2 (en) Cannula sealed shield assembly
CN103212143B (en) For performing the injection device of medicine injection
US8075547B2 (en) Autoflush syringe method
US20030199816A1 (en) Pre-loaded multi-chamber syringe
WO2002011793A1 (en) Kit preparation syringe, intermediate slide valve for syringes, and kit preparation
JP2000152989A (en) Injector and cartridge and plunger ring therefor
JP2002531227A (en) Needleless syringe with prefilled cartridge
CN1509195A (en) Pre-filled safety diluent injector
US20080171971A1 (en) Novel enhanced device and technique for mixing and dispensing a preserved agent
CN109328081B (en) Drug delivery device with pneumatic power unit
US20210146057A1 (en) Handheld Drug Delivery Device
US20220040413A1 (en) Devices and methods for delivery of substances within a prefilled syringe
WO1998010815A1 (en) Slide valve for syringes, syringe, and kit preparations
WO2001047587A1 (en) Slide valve for syringes, and plunger for slide valve-equipped syringes
JP2023516899A (en) Continuous tube with alternating composition for medical device
JP2002045422A (en) Syringe for kit pharmaceutical preparation, liquid flow path former and intermediate sliding valve for syringe type kit pharmaceutical preparation
JPH0529718Y2 (en)
JPH11253557A (en) Sliding valve for syringe, syringe and kit preparation
WO2024118184A1 (en) Devices and methods for delivery of substances within a prefilled syringe
JPH11253556A (en) Sliding valve for syringe, syringe and kit preparation
JPH0683042U (en) Intraoperative cholangiography catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP